Skip to content
10-Q

Quarterly Report

Damora Therapeutics, Inc. DMRA

0000950170-25-102963

← back to feed
Filed
Aug 5, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 1.32M sh
Shares Diluted Q2 2025 · Jun 30, 2025 1.32M sh
Shares Diluted Q2 2025 · Jun 30, 2025 1.32M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 1.08M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 1.08M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$4.68M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$10.04M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $10.21M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $14.18M
Stockholders Equity Q2 2025 · Jun 30, 2025 $10.95M
Stockholders Equity Q2 2025 · Mar 31, 2025 $13.71M
Stockholders Equity Q2 2025 · Dec 31, 2024 $15.83M
Stockholders Equity Q2 2025 · Jun 30, 2024 $23.59M
Stockholders Equity Q2 2025 · Mar 31, 2024 $28.16M
Stockholders Equity Q2 2025 · Dec 31, 2023 $32.33M
Current Liabilities Q2 2025 · Jun 30, 2025 $2.63M
Current Liabilities Q2 2025 · Dec 31, 2024 $1.2M
Total Liabilities Q2 2025 · Jun 30, 2025 $2.74M
Total Liabilities Q2 2025 · Dec 31, 2024 $1.3M
Current Assets Q2 2025 · Jun 30, 2025 $13.03M
Current Assets Q2 2025 · Dec 31, 2024 $16.84M
Total Assets Q2 2025 · Jun 30, 2025 $13.69M
Total Assets Q2 2025 · Dec 31, 2024 $17.13M
Eps Diluted Q2 2025 · Jun 30, 2025 −$2.60
Eps Diluted Q2 2025 · Jun 30, 2025 −$4.51
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$4.92
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$9.97
Eps Basic Q2 2025 · Jun 30, 2025 −$2.60
Eps Basic Q2 2025 · Jun 30, 2025 −$4.51
Eps Basic restated Q2 2025 · Jun 30, 2024 −$4.92
Eps Basic restated Q2 2025 · Jun 30, 2024 −$9.97
Sga Expense Q2 2025 · Jun 30, 2025 $1.96M
Sga Expense Q2 2025 · Jun 30, 2025 $3.88M
Sga Expense Q2 2025 · Jun 30, 2024 $2.78M
Sga Expense Q2 2025 · Jun 30, 2024 $6.05M
Rd Expense Q2 2025 · Jun 30, 2025 $1.47M
Rd Expense Q2 2025 · Jun 30, 2025 $2.14M
Rd Expense Q2 2025 · Jun 30, 2024 $1.83M
Rd Expense Q2 2025 · Jun 30, 2024 $4.3M
Net Income Q2 2025 · Jun 30, 2025 −$3.44M
Net Income Q2 2025 · Jun 30, 2025 −$5.97M
Net Income Q2 2025 · Jun 30, 2024 −$5.34M
Net Income Q2 2025 · Jun 30, 2024 −$10.82M
Operating Income Q2 2025 · Jun 30, 2025 −$3.42M
Operating Income Q2 2025 · Jun 30, 2025 −$6.02M
Operating Income Q2 2025 · Jun 30, 2024 −$5.58M
Operating Income Q2 2025 · Jun 30, 2024 −$11.32M